SecBot SecBot
SECBOTREPLAY Home › Report › DYN

DYN · Dyne Therapeutics elected Barry E

Dyne Therapeutics, Inc. · 8-K filed Jun 22, 2026 at 16:15 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Jun 22, 2026 at 16:15 ET

Dyne Therapeutics elected Barry E. Greene as an independent Class I director to its board. This is a routine board appointment with standard compensation under the non-employee director program, no material financial or strategic impact.

  • Barry E. Greene elected as Class I director effective June 22, 2026
  • Not appointed to any board committees
  • Received option to purchase 57,463 shares at $20.87 per share, vesting over 3 years
  • Annual cash compensation of $45,000 as board member

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access